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Abstract
Cancer is a disease that affects millions around the globe. Treatments such as radiation
and chemotherapy are often used to treat cancerous tumors, but are not 100% effective in curing
the patient. Alternatively, some research groups have proposed the use of metallointercalators,
metal complexes consisting of a rhodium, ruthenium, or iridium metal center with bidentate
supporting ligands such as bipyridine and phenanthroline, or tridentate ligands such as
terpyridine. The complexes also contain a bidentate intercalating group such as
dipyridophenazine. These complexes possess the ability to directly bind to DNA through
intercalation between the stacks of DNA base pairs, giving them the potential to be used as
probes to analyze and identify chemically damaged DNA. The ultimate goal would be to design
molecules that could detect damaged DNA at the molecular level and allow treatment before
tumors could develop. Our objective is to design and synthesize novel metallointercalator
complexes of rhenium, and to examine their physical and spectroscopic properties. Specifically,
we are attempting to prepare [Re(Py2NO)(dppz)L]3+, where L = H2O or NH3. (Py2NO = 4,4dimethyl-2,2-di(2-pyridyl)oxazolidine; dpk-OEt = (py)2C(O)OCH2CH3; dppz =
dipyridophenazine). Reaction of TBA2[Re2Cl8] with the nitroxide ligand Py2NO in acetonitrile
produces a red/brown compound proposed to be Re(Py2NO)Cl3. Isolation and purification of this
compound has proven to be a challenge. NMR studies indicate the compound is present as an
intractable mixture. When the same reaction is performed in ethanol, the blue complex ReO(dpkOEt)Cl2 is obtained. The same compound can be isolated in good yield by direct reaction of two
equivalents of di-2-pyridyl ketone with TBA2[Re2Cl8]. The blue complex has been reacted with
two equivalents of Ag+ followed by the addition of dppz to produce a brown solid believed to be
the metallointercalator [ReO(dpk-OEt)dppz]2+. Details of the synthesis along with IR, NMR, and
UV/Vis spectral characterization of these compounds are described.
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Introduction
Deoxyribonucleic acid (DNA) is the molecule responsible for holding all of the genetic
information of every cell in every living organism on the planet. DNA is a polymer which can
come in various lengths, depending on the amount of information required to facilitate the proper
function of a cell. This information is stored in the form of four primary bases: Adenine (A),
Thymine (T), Cytosine (C), and Guanine (G). In a structure of DNA (Fig. 1), these bases are
found in pairs: A pairs with T, and C pairs with G. The pairs are held together by weak

Figure 1: Molecular structure of A-T and C-G DNA base pairs.

interactions known as hydrogen bonds, which become extremely strong when combined in a
group, similar to a bundle of twigs.1 This stacking nature of DNA bases allows for DNA’s wellknown double-helix structure, which is maintained by the bases attaching to a negatively charged
sugar-phosphate backbone.2
DNA bases repeat in various orders throughout a molecule or sequence of DNA. The
order in which these bases appear in a sequence encodes the genetic information held in a cell.
The DNA can then be read by other molecules within a cell, and translated into what the base
sequences code for: proteins. In other words, the order of bases in a DNA sequence dictates how
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a specific protein is to be constructed. This properly constructed protein can then carry out a task
which helps to keep the cell functioning properly.2
Since DNA codes for proteins, which have an overwhelming diversity of structure and
function within cells and organisms, it is extremely important to ensure the DNA sequences that
code for these proteins remain the same. If even one base is altered or mutated, the structure and
function of the sequence’s corresponding protein can be affected.2 Some of the consequences of
this can include a protein whose creation was terminated prematurely, or a protein containing the
wrong amino acids. Both of these scenarios can prevent the protein from functioning properly in
the cell, because it does not have the proper structure to carry out its function. This lack of
function can in turn lead to diseases such as cancer.3
Over time, an organism’s DNA can accumulate multiple mutations as well as chemical
modifications. These can result in proteins being formed improperly, as the genetic information
that codes for the protein is either mutated or disrupted due to DNA damage. Thus, proteins may
not function properly due to their improper structure, which can have catastrophic consequences
for both a cell and an organism.
Fortunately, the human body has a mechanism to solve the problem of DNA mismatches:
mismatch repair (MMR) machinery. The DNA mismatch repair machinery consists of enzymes
that recognize and repair DNA mismatches, reducing their frequency by a factor of 1000.4–6 As
with other aspects in the genome, however, there can be mutations in the MMR genes, known as
MMR deficiencies. MMR deficiencies increase the amount of unchecked DNA mutations, which
can result in an increased risk for developing cancers.6 To add insult to injury, it has been shown
that MMR deficiencies are associated with an increased tolerance to traditional
chemotherapeutics such as cisplatin, carboplatin, doxorubicin, and mercaptopurine.5,7 MMR

6
deficiencies are therefore a high-priority target for cancer recognition treatment. There are other
mechanisms in cells to repair DNA damage, known as lesions, which work similarly to the
mismatch repair machinery. Like MMR deficiencies, deficiencies in the DNA lesion repair genes
can lead to increased DNA damage in cells, and thus a higher risk for developing cancer.
One proposed treatment solution to cancer and other genetic disorders is DNA repair.
Disorders such as cancers, Huntington’s disease, cystic fibrosis, sickle cell anemia, and even
Alzheimer’s and Parkinson’s diseases have been linked to missing, mismatched, or chemically
damaged DNA.3 The way to treat these diseases would be to treat them at the smallest level
possible: repairing or replacing the damaged or missing DNA sequence to reflect the complete,
undamaged sequence. Consequently, the cell would now be able to properly carry out its
function by synthesizing the complete protein required to carry out the function that the cell was
previously unable to do. Repairing MMR deficiencies would be advantageous as well, as the cell
would then be able to perform gene repair without outside assistance.
In order to repair damaged DNA, it must be found. Thus, molecules that can selectively
recognize and bind to DNA would be highly valuable. One such class of molecules, known as
metallointercalators, has been shown to act as a DNA probe with some success. A
metallointercalator, as shown by Figure 2, is a metal complex which contains a metal center, one
or more supporting ligands, and an intercalating group.

Figure 2: Diagram of a general metallointercalator complex, showing the metal ion,
supporting group, and intercalating group.
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The binding mode of a metallointercalator complex to DNA consists of three
components, which work in concert: the first, and typically strongest, binding component is an
electrostatic interaction between the positively-charged metal complex and the negativelycharged sugar-phosphate backbone of DNA. The second component consists of aromatic pistacking interactions between the aromatic, hydrophobic intercalating group and the aromatic
DNA base pairs. Finally, hydrogen bond interactions can take place between the capping ligand
or ancillary groups on the metallointercalator complex and the hydrogen bond donors and
acceptors on the sugar-phosphate backbone of DNA. This provides added stability for the
complex when bound to DNA, and can be used to recognize specific base pair sequences.
The metal ion is the centerpiece of the metallointercalator complex. Acting as a
foundation, the metal center is the site to which the supporting ligand, intercalating group, and
ancillary groups coordinate. The metal center also provides the complex with a net positive
charge. A more positively-charged metal center allows for a stronger electrostatic interaction
between the positively-charged metallointercalator and the negatively-charged DNA backbone.
The most extensively used metal centers for these complexes have traditionally been RhIII and
RuII/III.8 These metals possess low spin d5 and d6 configurations which renders them inert with
respect to ligand substitution or exchange.8
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Figure 3: Diagram of an iridium metallointercalator complex highlighting the possible
variation in polypyridyl intercalating groups. Bipyridine, phenanthroline, dpq, dppz, and
dppn are shown.21

The intercalating group is the ligand which inserts between the DNA base pairs, similar
to sliding between the rungs of a ladder. Intercalating groups are planar, hydrophobic, aromatic,
organic compounds consisting of three to five or more rings. Most intercalating groups are
bidentate, coordinating to the metal center through two nitrogen atoms. Common examples are
dipyridophenazine (dppz), a conjugated five-ring system containing four nitrogen atoms, two of
which coordinate to the metal center, as well as phi, a conjugated three-ring system that
coordinates to the metal center through two nitrogen atoms (Fig. 2). Figure 3 shows the possible
variation in polypyridyl intercalating groups like dppz, highlighting the ability to adjust the
length of the intercalator. When bound to DNA, intercalating groups exhibit both hydrophobic
and pi-stacking interactions with the DNA base pairs, contributing to the stability of the
metallointercalator-DNA complex as a whole.
One important property of several metallointercalator complexes is their ability to emit
light upon intercalation, otherwise known as “light-switch complexes”. One such complex is
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[Ru(bpy)2(dppz)]2+ (bpy = bipyridine), shown in Figure 4. This metal complex does not fluoresce
when by itself in aqueous solution, but when bound to DNA, the complex emits red light.9 This
is due to water hydrogen bonding to the nitrogen atoms of dppz when in solution, preventing the
emission of light. When interacting with DNA, however, dppz is intercalated between the base
pairs in the hydrophobic region of DNA. Thus, water is unable to hydrogen bond with dppz’s
nitrogen atoms, allowing for light emission.9 This unique property has the potential to be applied
to other metallointercalator complexes, possibly allowing for differing
fluorescent properties based on the substituent and supporting groups bound to the metal ion
center.
Many of the known light-switch complexes are Ru-dppz based intercalators. Another
intercalator variation, based on Rh-phi, has demonstrated the ability to cleave DNA strands when
exposed to UV light in the 313-325 nm range.10,11 Two examples of these photocleaving
metallointercalators are [Rh(phen)2(phi)]3+ and [Rh(phi)2(bpy)]3+ (Fig. 5). In addition, it has

Figure 4: Chemical structure of the light-switch
complex [Ru(bpy)2(dppz)]2+.9
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Figure 5: Chemical structures of two Rh-phi metallointercalator complexes,
[Ru(phen)2(phi)]3+ and [Rh(phi)2(bpy)]3+, with the ability to photocleave DNA. The mode of
DNA recognition, binding, and cleavage is dependent on the structure of the metal
complexes.11

been discovered that the shape of these complexes dictates their method of DNA recognition and
cleavage. In other words, the shape of each complex, or the way it is designed, changes how the
complex recognizes, binds to, and cleaves the DNA strand.11
Although extensive work has been conducted in the synthesis and characterization of
rhodium and ruthenium metallointercalators, rhenium-based metallointercalator complexes are
largely unknown. To date, there has been one known report of a ReI-dppz complex used as a
metallointercalator12: [Re(CO)3(4-MePy)dppz]+ (4-MePy = 4-methylpyridine), shown by Figure

Figure 6: Chemical structure of the first reported rhenium-based metallointercalator
complex: [Re(CO)3(4-MePy)dppz]+.12
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6. This complex was shown to intercalate into DNA, and like the RuII complexes previously
mentioned, the complex exhibited fluorescence upon intercalation.12 It has also been found that
ReI intercalators possess the ability to photocleave DNA.13
Further research was conducted with essentially the same complex, [Re(CO) 3(Py)dppz]+,
where 4-methylpyridine was substituted with pyridine (Py). During their research into amyloid
beta peptide aggregation and its affects in Alzheimer’s disease, Martí et al. discovered that
[Re(CO)3(Py)dppz]+ also exhibits fluorescence in the presence of amyloid beta, in addition to
DNA.14
Some research groups have worked with metalloinsertors, rather than
metallointercalators, and it is important to highlight this distinction. A metallointercalator is a
complex whose planar substituent group intercalates into, or inserts between, DNA base pairs.
The DNA must stretch (which increases its viscosity) in order to accommodate the intercalating
substituent of the metal complex, however the DNA strand remains intact.8,15 Conversely,
metalloinsertors interact with DNA in a way that results in the ejection of one or more bases
from a strand of DNA.10 This can be advantageous, as Barton et al. discuss the ability of the
metalloinsertor [Rh(bpy)2(chrysi)]3+ to eject DNA mismatches, resulting in recognizable DNA
lesions which have been shown to cause selective cell death of MMR-deficient cells, but not
MMR-proficient cells.15
Despite their differences, parallels can be drawn between metallointercalators and
metalloinsertors, and lessons can be learned in the design and application of metallointercalators.
Barton et al. reported in 2011 that rhodium-based metalloinsertors cause necrosis in MMRdeficient cells. This is interesting, as cancer treatment has traditionally centered on inducing
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apoptosis, or programmed cell death, in a cancer cell. Unlike apoptosis, necrosis is cell death
resulting from causes outside the cell, such as injury or lack of blood flow.6
Barton et al. further suggest necrosis as a pathway to cancer treatment, as necrosis
releases cytokines, an agent in the inflammatory response. They argue that this inflammatory
response would allow the immune system to then selectively target and eliminate the necrotic
cancer cells.6 Similarly, one effective design of a metallointercalator would be one which
selectively targets DNA mutants and causes necrosis in cancer cells.
The supporting ligand is an organic scaffold which typically contains nitrogen and/or
oxygen, and coordinates to the metal center through these atoms. The ligand can be either
bidentate, tridentate, or tetradentate, and provides stability to the metal complex, coordinating to
sites on the metal which would otherwise be unutilized. There are many forms a supporting
ligand can take, however the general structure is based on either a carbon-nitrogen ring or a
series of connected pyridine rings. Supporting ligands generally occupy four of the six
coordination sites on the metal center, and can be composed of two identical bidentate ligands or
a single tetradentate ligand. It is also important that these ligands are neutral or monoanionic in
order to preserve the positive overall charge of the metal complex.
Some classic examples of supporting ligands are bipyridine (bpy), terpyridine (terpy),
and phenanthroline (phen), as shown in Figure 7. Many examples of metallointercalator
complexes mentioned herein contain two bpy or phen molecules, or derivatives thereof, acting as
supporting ligands. This method allows the supporting ligands to occupy four of the metal
center’s coordination sites, leaving two sites available for a bidentate intercalating group. Bpy,
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Figure 7: Terpyridine (left), bipyridine (center), and phenanthroline (right), classic examples
of supporting ligands in metallointercalators with the inability to hydrogen bond.
phen, and terpy, however, are unable to hydrogen bond with the DNA backbone, as they lack
hydrogen bond donors or acceptors. Furthermore, their only two hydrogen bond acceptors, both
nitrogen atoms, are coordinated to the metal center. The lack of ability for these supporting
ligands to hydrogen bond with the DNA backbone will consequently have an impact on the
stability of the metallointercalator complex when bound to DNA.
There are, however, supporting ligands that contain hydrogen bond donors and acceptors,
and are thus able to hydrogen bond with the DNA backbone. There are many advantages of this,
some of which include additional stability of the metallointercalator when bound to DNA and the
ability to fine tune the binding of the metallointercalator to specific DNA sequences.
Previous work by Jacqueline Barton et al. has demonstrated the ability of the
metallointercalator complex Λ-1-Rh(MGP)2phi5+ to be specific to the DNA sequence 5’CATATG-3’ (Fig. 8). The supporting group is able to hydrogen bond to the DNA backbone,
providing the complex with increased stability. In addition, the metallointercalator bound
competitively to the DNA sequence which is also bound by transcription factors for the gene
following the sequence. Thus, the transcription factors were unable to bind to the DNA
sequence, and were unable to dictate the synthesis of the protein that the gene following the
sequence codes for.16
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Figure 8: Molecular structure of Barton et al.’s DNA specific intercalator Λ-1Rh(MGP)2phi5+. 16
This gene-inhibiting property of a DNA sequence-specific metallointercalator could be
advantageous. For example, if a sequence on a gene were damaged or mutated, a
metallointercalator would be able to bind to the gene while the DNA sequence was repaired,
preventing the cell from synthesizing a protein with an improper structure, which would not be
able to carry out its necessary function. Once the DNA sequence was repaired, the
metallointercalator would be removed from the DNA, allowing the cell to begin producing the
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Figure 9: Chemical structure of the cytotoxic metal complex mer-[Ru(terpy)Cl3]. This
complex, which intercalates via the terpy ligand, demonstrates cytotoxicity and antitumor
activity toward human cervix carcinoma cells.

protein which would now have a complete structure, rendering the protein fully functional once
again.
Another metallointercalator produced by Barton et al. showed specificity for a single
mismatch on a strand of DNA containing 2,725 base pairs.17 Mismatches are ideal targets for
metallointercalators because they are indicators of thermodynamic instability on a strand of
DNA, due to their poor pi-stacking ability and loss of hydrogen bonding.6
In addition to showing sequence specificity, some metallointercalators have shown both
cytotoxicity and antitumor activity. For example, mer-[Ru(terpy)Cl3] (terpy = terpyridine) has
shown cytotoxicity toward human cervix carcinoma cells in vitro (Fig. 9). In addition to
cytotoxicity, this complex has demonstrated antitumor activity in the same cell line. 18
Capping ligands are another option that can be used in lieu of supporting ligands. A
capping ligand, unlike a supporting ligand, is tridentate. In binding to three of the metal’s
coordination sites instead of four, the capping ligand allows for an open binding site on the metal
complex, which can be modified by coordinating various ancillary groups to the metal center.
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This would further allow for modification of the metallointercalator’s binding, reactive, and
physical properties. Terpy is a classic example of a capping ligand. Like other supporting
ligands, however, capping ligands with the ability to hydrogen bond with the DNA backbone
would provide more stability to the metallointercalator and increased opportunity for sequence
specificity.
As previously mentioned, capping ligands allow for the utilization of ancillary groups
which coordinate to the metal center through an open binding site. These ancillary groups can be
modified, thereby altering the behavior of the complex in solution, when it is bound to DNA, and
can even inhibit intercalation.8 Changing the ancillary group allows for control of the metal
complex’s physical and chemical properties such as hydrophobicity, binding affinity, sequence
selectivity, and cellular uptake.19 Greater control over the behavior of a metallointercalator
translates to more efficient and more effective cancer treatments with fewer side effects. For
example, some ancillary groups may provide the complex with a greater ability to hydrogen
bond with the DNA backbone. Others may only interact with select DNA sequences, making
some DNA sequences a specific target for the metallointercalator.

Figure 10: A general diagram showing a bi-metallointercalator system where two individual
intercalators are linked by a linking molecule. An example is shown from Thomas et al. using
the ReI intercalator shown above.13
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In addition to using the open binding site of the metallointercalator for ancillary groups,
metallointercalators can be linked to one another through their open binding sites via a linking
molecule (Fig. 10). Jim Thomas et al. have exploited this property using ReI-dppz metal
complexes, using the linkers 1,2-di(4-pyridyl)ethane (dpe) and 1,3-di(4-pyridyl)propane (dpp).13
Sheldrick et al. have conducted similar studies with Ir-dppz complexes, using both
pyrazine and 4,4’-bipyridine to link intercalators at the open binding site of the metal center.20 In
addition, Sheldrick et al. discuss cytotoxic chlororhodiumIII complexes containing tridentate
supporting ligands such as 1,4,7-trithiacyclononane and tris(pyrazolyl)methane (tpm).21 These
complexes allow for the coordination of a bidentate intercalating group such as dppz, and could
then be linked together after substitution of the chlorine for any of the aforementioned linking
molecules.
Previous Work
Previous work in the Haefner group has focused on using 1,4,7-triazacyclononane (tacn)
as a capping ligand. Tacn is a tridentate capping ligand that allows for an open binding site on
the metal center to which ancillary groups or linkers may bind. Unlike bpy, terpy, and
phenanthroline, however, tacn contains three N-H groups, which have the ability to hydrogen
bond to the DNA backbone. This hydrogen bonding ability of the capping ligand would provide
the metallointercalator with an affinity for specific DNA sequences and more stability when
bound to DNA.
The use of tacn in the Haefner group has been successful in metallointercalators
containing a variety of metal centers, including RuII, IrIII, and RhIII. Previous examples include
the metallointercalators [Ru(tacn)(dppz)(DMSO)]2+, [Ir(tacn)(dppz)(DMSO)]3+,
[Rh(tacn)(dppz)(H2O)]3+ (Fig 11).22–25 One of these metallointercalators,
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Figure 11: Three metallointercalator complexes containing the tacn capping ligand
previously synthesized by the Haefner group. From left to right: [Ru(tacn)(dppz)(DMSO)]2+,
[Ir(tacn)(dppz)(DMSO)]3+, [Rh(tacn)(dppz)(H2O)]3+.

[Rh(tacn)(dppz)(H2O)][CF3SO3]3, underwent preliminary DNA binding studies with calf-thymus
DNA. Another DNA intercalator, ethidium bromide, was used as a fluorescence probe in the
study. It was found that [Rh(tacn)(dppz)(H2O)]3+ replaced the ethidium bromide when it
intercalated into DNA, resulting in the quenching of fluorescence, shown by Figure 12. This
result indicated that [Rh(tacn)(dppz)(DMSO)]3+ had a higher binding affinity to DNA than
ethidium briomide.

A: 0.0 μM
B: 2.0 μM
C: 5.0 μM
D: 8.0 μM

Figure 12: Absorption spectrum of DNA binding studies of [Rh(tacn)(dppz)(H2O)]3+with calfthymus DNA using ethidium bromide as a fluorescence probe. Each curve corresponds to the
fluorescence level with various concentrations of [Rh(tacn)(dppz)(H2O)]3+ ranging from 0 to
8 μM. Emission decreases with increasing concentration of [Rh(tacn)(dppz)(H 2O)]3+.
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Current Work
In an effort to develop new metallointercalators with different supporting groups, we
began the examination of the tridentate ligand 4,4-dimethyl-2,2-di-2-pyridyl oxazolidine
(Py2NO). Previously, this capping ligand has been used to prepare first-row metal complexes
with the general formula of M(Py2NO)2n+, where M = Mn, Fe, Co, and Cu (Fig. 13).26–29 These
complexes were found to exhibit unusual magnetic properties including spin-crossover
intermolecular ferromagnetic exchange and single molecule magnetism. 30

Figure 13: Molecular structure of [Mn(Py2NO)2]2+, showing the tridentate nature of Py2NO
and its coordination behavior to the metal center. Murray et al. suggest that the Mn 2+ ion is
in a high-spin d5 state, whereas our Re3+ ion is expected to be in a low-spin d4 state, possibly
suggesting a difference in behavior of these metal ions even though they reside in the same
group.
Our interest in the ligand derives from its tridentate nature. Py2NO would function as a
capping ligand, making available the sixth coordination site of the metal center. Furthermore, the
oxygen donor atom could act as a hydrogen bond acceptor, forming a hydrogen bond with the
DNA backbone and thus providing more stability to the metallointercalator. Finally, the radical
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nature of the hydroxide group could impart additional reactivity upon intercalation of the
complex with DNA.
To date, there have been no reports of using Py2NO to support second or third-row metal
ions. We are particularly interested in using Py2NO to develop new metallointercalator
complexes of rhenium. As previously mentioned, metallointercalators of rhenium are relatively
unknown, with the only reported Re-dppz metallointercalator having a charge of +1. Our target is
the metallointercalator [Re(Py2NO)(dppz)H2O]3+ (Fig. 15). This metallointercalator is novel in
many ways, one of which is the utilization of the ReIII oxidation state instead of ReI. The Py2NO
group will bind to the Re3+ ion through its two nitrogen atoms on the molecule’s pyridine rings,
as well as through a free radical oxygen which is part of a nitroxide on the oxazolidine ring. The
dppz group will bind to the Re3+ ion through two of its nitrogen atoms. Figure 14 shows the open
binding site, designated by “L”, to which ancillary groups may bind.
This metallointercalator design has the potential to show various interesting properties.
One such property, for example, is the ability to be tuned to bind to specific DNA sequences.
Due to the complex’s open binding site, this metallointercalator’s physical and chemical
properties will change, depending on the substituent bound to the open binding site of the
complex. For example, some substituents may allow for increased hydrogen bonding between
the metallointercalator complex and the DNA, thus allowing for more stability of the interaction

Figure 14: A diagram of one of our proposed metallointercalators. Emphasis is placed on the
open binding site, designated by the bolded “L”, which allows for the fine-tuning of the
physical and chemical properties of the complex.
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between the metallointercalator and the DNA. Conversely, another substituent may inhibit
hydrogen bonding between the metal complex and the DNA at that or another specific site.
Another property that we expect this metallointercalator complex to exhibit is the ability
to emit light when bound to DNA. As mentioned previously, some metallointercalator complexes
containing dppz have been shown to fluoresce when bound to DNA, behaving as a “light
switch”. This property would facilitate the process of identifying DNA damage, reducing the
time required for the DNA damage to be repaired.
Herein, we describe the synthesis and characterization of the metallointercalator
intermediate Re(Py2NO)Cl3. We have also discovered another intermediate, ReO(dpk-OEt)Cl2, a
known complex which has been synthesized through a novel method in higher yield. A
compound believed to be the metallointercalator [ReO(dpk-OEt)dppz]2+ has been synthesized as
well. The syntheses of these compounds, their physical and chemical properties, as well as data
obtained from infrared spectroscopy, UV/Vis spectroscopy, and x-ray diffraction studies will be
described.

Figure 15: Chemical structure of one of our proposed novel metallointercalators:
[Re(Py2NO)(H2O)dppz]3+. A shorthand for Py2NO is shown to the right of the structure.

Experimental Section
Materials and Methods. All reagents and solvents were purchased from commercial
sources and used without further purification. Unless otherwise noted, all reactions were
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conducted in an argon atmosphere using standard Schlenk line techniques. Work up of products
was performed in air.

Characterization Techniques. Powders and crystals were analyzed by IR spectroscopy
using a PerkinElmer® Frontier FT-IR/NIR Spectrometer. UV/Vis analysis was conducted using
both a PerkinElmer® Lambda 25 UV/Vis Spectrometer and a Hewlett-Packard® Model 8453
diode array spectrometer in the solvents specified by the synthetic procedure. NMR spectral data
was obtained using a JEOL 400 mHz spectrometer in deuterated solvents specified by the
synthetic procedure. Chemical shifts were referenced using the known chemical shifts of the
protio impurity in the deuterated solvent. X-ray diffraction studies were conducted by Dr. James
Golen at the University of Massachusetts, Dartmouth. Data were collected at 24 oC on a Bruker
D8 Venture X-ray instrument using Mo K alpha radiation and data were corrected for absorption
with SADABS. Structure was solved by direct methods and all non-hydrogen atoms of main
molecule were refined anisotropically by full matrix least squares on F2. All hydrogen atoms
were placed in calculated positions with appropriate riding parameters.

Synthetic Procedures.
4,4-dimethyl-2.2-di(2-pyridyl)oxazolidine (Py2NO). Synthesis of Py2NO was adapted
from a literature procedure.26 Di(2-pyridyl)ketone (9.71 g, 51.7 mmol), 2-amino-2methylpropanol (110 mL, 1.13 mol), and concentrated sulfuric acid (25 drops) were added to 200
mL of toluene and refluxed for four days. The solution was then cooled to room temperature and
concentrated. Water (200 mL) and diethyl ether (100 mL) were then added to the solution,
forming aqueous and organic layers. The organic layer was separated, and the aqueous layer was
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extracted twice with CH2Cl2 (100 mL). The organic layers were combined and dried with
MgSO4, and the solvents were evaporated, yielding an intermediate compound.26
The intermediate (3.01 g, 11.8 mmol) was mixed with diethyl ether (40 mL), and the
solution was cooled on ice. Added to this solution was a solution containing metachloroperoxybenzoic acid (MCPBA, 4.34 g, 17.6 mmol) in 40 mL of diethyl ether. The reaction
mixture was allowed to stand for four hours. A cold, 5% Na2CO3 solution (40 mL) was added to
the reaction mixture to separate the aqueous and organic layers. The organic phase was extracted
four times with the Na2CO3 solution (40 mL), while the aqueous phase was extracted five times
with CH2Cl2 (40 mL). The organic phases were combined, washed twice with cold 5% Na2CO3
solution (40 mL), and dried with MgSO4. The solvents were evaporated under vacuum, yielding
an orange solid.26 The orange solid was chromatographed on silica gel with acetone. Yield: 2.20
g (68%). IR (cm-1): 3055 w, 2975 w, 2873 w, 1682 m, 1586 s, 1571 m, 1541 m, 1464 s, 1435 s,
1363 m, 1318 m, 1245 m, 1051 s, 992 s, 944 s, 775 s, 751 s. UV/Visible (CH3CN; λmax, nm):
260.
Tetrabutylammonium Octachlorodirhenate (TBA2[Re2Cl8]). Synthesis of
TBA2[Re2Cl8] was adapted from a literature procedure.31 TBA[ReO4] (1.5 g, 3.04 mmol) was
added to a 100 mL Schlenk flask, and the flask was filled with argon. Benzoyl chloride (15 mL,
129 mmol) was then syringed into the flask, resulting in a pale yellow solution, which changed in
color from pale yellow to orange, red, and eventually dark green as the solution was heated. The
flask was fitted with a reflux condenser and the solution was gently refluxed overnight (20-24 h).
After 24 h, the reaction was cooled to room temperature, and a solution containing
tetrabutylammonium bromide (2.5 g, 7.75 mmol), ethanol (35 mL), and concentrated aqueous
hydrochloric acid (5 mL) was added to the reaction mixture. This solution was allowed to reflux
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for an additional hour, after which it was cooled to room temperature and evaporated to roughly
25-30 mL using a rotary evaporator. The solution was then filtered through a 30 mL medium
porosity sintered glass frit, and the resulting blue crystals were washed with 3 5-mL portions of
ethanol, 10 mL of diethyl ether, and dried under vacuum.
The crude product was added to stirred, boiling methanol (50 mL) containing one drop of
concentrated aqueous hydrochloric acid, then immediately filtered through a 30 mL medium
porosity sintered glass frit into concentrated aqueous hydrochloric acid (50 mL). Some dark blue
crystals precipitate at this stage and were isolated. Evaporation of the methanol via a rotary
evaporator yields more crystals. Yield: 1.32 g (76%). IR (cm-1): 2954 s, 2876 s, 1476 s, 1381 s,
1179 w, 1152 m, 1107 w, 1051 w, 1025 m, 879 s, 796 w, 736 s. UV/Visible (CH3CN; λmax, nm):
685.
Re(Py2NO)Cl3. TBA2[Re2Cl8] (100 mg, .088 mmol) and Py2NO (47.4 mg, 0.175 mmol)
were refluxed in CH3CN (5 mL) in air for 24 hours. The acetonitrile was removed under vacuum,
leaving a brown, oily product to which 10 mL each of acetone and hexane were added (1:1
volumetric ratio). The solvents were removed using a rotary evaporator, resulting in the
formation of a red/brown solid which was washed with ethanol and filtered using a Hirsch
funnel. IR (cm-1): 3082 w, 2963 w, 2871 w, 1604 m, 1653 m, 1441 s, 1283 m, 1236 m, 1164 m,
1093 m, 1028 m, 965 m, 912 m, 766 s. UV/Visible (CH3CN; λmax, nm): 485, 272. 1H NMR (400
MHz, CD3CN, δ): 8.75 (t, 1H, py), 8.2 (q, 2H, py), 7.6 (d, 1H, py), 3.05 (s, 2H, -CH2), 0.95 (s,
6H, (-CH3)2).
ReO(dpk-OEt)Cl2 (Method A). TBA2[Re2Cl8] (100 mg, 0.088 mmol) and Py2NO (47.4
mg, 0.175 mmol) were refluxed in ethanol (10 mL) under argon for 24 hours. The solution
turned green upon addition of the ethanol, and became very dark within 15 minutes. A blue
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precipitate formed after 24 hours, and was filtered using a Hirsch funnel and washed with diethyl
ether. The solid was dissolved in methylene chloride, and the solvent was allowed to slowly
evaporate. Dark blue crystals formed upon evaporation of the methylene chloride. Yield: 30 mg
(34%). Infrared, UV-visible, and NMR spectroscopic data of the sample were also obtained. IR
(cm-1): 3073 w, 2978 w, 1601 m, 1438 m, 1280 m, 1233 s, 1218 m, 1170 m, 1120 w, 1093 m,
1045 m, 1007 m, 965 s, 953 m, 891 w, 805 m, 766 s, 698 s, 671 s. UV/Visible (CH3CN; λmax,
nm): 342, 315, 249. 1H NMR (400 MHz, (CD3)2SO, δ): 8.42 (d, 2H, py), 8.05 (q, 4H, py), 7.78
(t, 2H, py), 3.65 (q, 2H, -OCH2CH3), 1.30 (t, 3H, -OCH2CH3).
ReO(dpk-OEt)Cl2 (Method B). TBA2[Re2Cl8] (250 mg, 0.219 mmol) and di-2-pyridyl
ketone (80.7 mg, 0.438 mmol) were refluxed in ethanol (10 mL) in air. The reaction proceeded
as previously described, with the solution turning light green upon addition of ethanol and darker
green within 15 minutes. A blue precipitate formed after 24 hours of reflux, and was filtered
through a Hirsch funnel and washed with ethanol and diethyl ether. The crude product was
dissolved in methylene chloride and filtered through a 5.75” inch glass pipet filter containing
roughly 0.5 cm of Celite® into a 20 mL scintillation vial. The vial was then covered with
Parafilm pierced with seven evenly distributed holes, and the solvent was allowed to slowly
evaporate. Blue crystals formed upon evaporation of the solvent. Yield: 178 mg (81%).
[ReO(dpk-OEt)dppz]2+. ReO(dpk-OEt)Cl2 (50 mg, 0.995 mmol), silver
trifluoromethanesulfonate (50.9 mg, 0.198 mmol), and dppz (28.6 mg, 0.101 mmol) were added
to CH3CN (5 mL) in a 50 mL round-bottomed flask. The solution was then gently refluxed in air
for 24-28 hours. A gray/green precipitate formed and was filtered off using a Hirsch funnel. The
resulting dark red filtrate was then pipet filtered through roughly 0.5 cm of Celite®. The solution
was cooled on ice, and saturated aqueous potassium hexafluorophosphate was subsequently
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added. The solution then appeared as a brown suspension as [ReO(dpk-OEt)dppz][PF6]2
precipitated. The red/brown precipitate was then isolated by filtration through a medium porosity
sintered glass frit before being dried under vacuum. The compound believed to be [ReO(dpkOEt)dppz][PF6]2 was then dissolved in acetone and the solution was pipet filtered through 0.5 cm
of Celite®. In a 20 mL scintillation vial, 5 mL of this solution was layered with toluene (5 mL),
and the acetone was allowed to evaporate. Small, cube-shaped, red-orange crystals formed.
Yield: 83.7 mg (42%). IR (cm-1): 3642 w, 3099 w, 1700 w, 1608 m, 1497 m, 1423 m, 1360 m,
1238 m, 1080 m, 1038 m, 957 m, 829 s, 763 s, 728 s. UV/Visible (CH3CN; λmax, nm): 374, 358,
277. 1H NMR (400 MHz, CD3CN, δ): 9.70 (d, 1H, py), 8.50 (q, 2H, dppz), 8.17 (q, 1H, py), 7.97
(d, 1H, dppz), 7.83 (t, 1H, py), 0.95 (t, 1H, -OCH2CH3).

Results and Discussion
Synthesis of Py2NO

Figure 16: Chemical reaction of di-2-pyridyl ketone, 2-amino-2-methyl propanol, and
MCPBA to produce the tridentate ligand Py2NO.

The Py2NO ligand was synthesized first by the reflux of di-2-pyridyl ketone, 2-amino-2methyl propanol, and sulfuric acid in toluene (Fig. 16). The solution was a bronze color upon
addition of the reagents. Upon quenching of the reaction, the solution appeared to be two layers,
with a gold colored top layer and a smaller, cloudy layer on the bottom which contained some
precipitate. The organic product was isolated from the aqueous byproduct, and this solution was
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light amber in color. A crude, solid product was later obtained, and was light yellow in color
with a chalky texture.
This crude product was then oxidized with 3-chloroperoxybenzoic acid (MCPBA) to
produce the nitroxide product. The reaction mixture changed in color from green to yellow and
eventually orange. The crude product was then chromatographed on silica gel with acetone,
yielding the pure Py2NO ligand.
Synthesis of Re(Py2NO)Cl3
Our initial objective was to react two equivalents of Py2NO with the Re3+ precursor
[TBA]2[Re2Cl8] in an effort to prepare the intermediate Re(Py2NO)Cl3 (Fig. 17). We then
envisioned that removal of the halides followed by addition of dppz would lead to the new
rhenium-based metallointercalator [Re(Py2NO)(dppz)L]3+ (L = CH3CN or H2O). Reaction of
Py2NO with [TBA]2[Re2Cl8] under reflux with CH3CN in air produced a dark red/brown
solution. Similar results were obtained under reflux conditions, as well as in other aprotic
solvents such as acetone. Removal of the solvent under vacuum consistently produced an oily,
intractable solid. We found that a red/brown precipitate could be obtained by the slow addition of
equal volume of hexane to acetone solutions of the product, which were then evaporated under
vacuum. The crude, red/brown solid compound was soluble in polar aprotic solvents, specifically
acetone, acetonitrile, and methylene chloride.
An IR spectrum of the crude solid exhibited vibrations similar to that of free Py2NO but
shifted from 0 to 30 cm-1, strongly suggesting coordination of the ligand to the rhenium metal
center. The electronic absorption spectrum of the solid contained absorbances at 485 and 272
nm. The Re2Cl82- δ-δ* transition at 685 nm, however, was absent, indicating that cleavage of the
Re-Re quadruple bond had occurred.
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Figure 17: Chemical reaction of TBA2[Re2Cl8] and Py2NO in acetonitrile to produce the
intermediate Re(Py2NO)Cl3.

The 1H NMR spectrum of the solid (Fig. 18) revealed a complex set of broad resonances
in the aromatic region. The broadness of the resonances is indicative of a paramagnetic species.
Cleavage of the Re-Re quadruple bond would produce a mononuclear Re3+, low spin d4 center
that would be expected to be paramagnetic. It appears as though there are two sets of aromatic
resonances. The first set consists of broad resonances at 8.75, 8.2, and 7.6 ppm. This would be
consistent with a symmetric Re(Py2NO) species such as Re(Py2NO)Cl3, where the two pyridyl
groups would be equivalent. There is also a more intense resonance at 1.0 ppm which integrates
for roughly seven protons. This resonance corresponds to the dimethyl group on the oxazolidine
ring. The methylene protons of the ring appear at 3.0 ppm. The second set of resonances in the
aromatic region are more numerous and suggest a Py2NO complex that lacks mirror symmetry,
thus making the pyridyl rings inequivalent. Similar resonances appear upfield in the methyl and
methylene regions.

Figure 18: NMR Spectrum showing the metal complex believed to be Re(Py2NO)Cl3 in deuterated acetonitrile. The enlarged
aromatic region (9-7ppm) suggests coordination of Py2NO with the metal complex. We also expected this complex to be
paramagnetic. The broadness of the aromatic peaks suggests that the complex may be paramagnetic, possibly providing further
evidence of the identity of this metal complex as Re(Py2NO)Cl3.
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Unfortunately, attempts to obtain single crystals of the intermediate Re(Py2NO)Cl3 have
been unsuccessful, and further studies will need to be conducted in order to properly characterize
this complex as Re(Py2NO)Cl3. The yields of this product were very low, and were insufficient
for the synthesis of the metallointercalator [Re(Py2NO)(dppz)H2O]3+. It is important to note that
since the complex is expected to be paramagnetic, the exact oxidation state of the metal will be
complicated by the presence of the nitroxide radical of Py2NO. Regardless of the metal oxidation
state, however, that the overall charge of the complex should remain 3+.
Synthesis of ReO(dpk-OEt)Cl2
Surprisingly, the reaction between TBA2[Re2Cl8] and Py2NO in alcohols such as ethanol
under argon resulted in the precipitation of a blue solid (Fig. 19). Single crystals of this blue
complex were obtained by dissolution in and slow evaporation of methylene chloride. An x-ray

Figure 19: Chemical reaction of TBA2[Re2Cl8] and Py2NO in ethanol to produce the
intermediate ReO(dpk-OEt)Cl2.

diffraction study on the compound revealed it to be the ReV oxo complex ReO(dpk-OEt)Cl2.
Apparently, this reaction results in the decomposition of the Py2NO ligand to reform di-2-pyridyl
ketone, which then reacts with ethanol to form the dpk-OEt ligand. While the origin of the ReV
oxo is unknown, it appears likely to be derived from the nitroxide oxygen of the Py2NO. Transfer
of the oxygen to the rhenium metal center facilitates further decomposition of Py2NO. Additional
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Figure 20: Chemical reaction of TBA2[Re2Cl8] and di-2-pyridyl ketone in ethanol to produce
the intermediate ReO(dpk-OEt)Cl2.

studies are required to identify the source of the oxo group and the decomposition byproducts of
the Py2NO ligand.
This ReV oxo sample can be prepared in much higher yield through the direct reaction of
TBA2[Re2Cl8] with di-2-pyridyl ketone in ethanol in air (Fig. 20). In fact, the yield for ReO(dpkOEt)Cl2 using TBA2[Re2Cl8] is higher than that previously reported by Gonzàlez et al. using
TBA[ReCl5(DMF)] as a precursor.32 A proposed mechanism of this reaction is shown by Figure
21, which suggests that coordination of the nitrogen atoms to the metal activates the carbonyl
carbon of di-2-pyridyl ketone. Ethanol acts as a nucleophile, attacking the carbonyl carbon which
then produces the dpk-OEt ligand.

Figure 21: Proposed mechanism of the formation of the dpk-OEt. Metal coordination
activates the carbonyl carbon of the di-2-pyridyl ketone, causing the reversible addition of
ethanol acting as a nucleophile.
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Figure 22: NMR spectrum of ReO(dpk-OEt)Cl2 (with integration) in deuterated DMSO. The enlarged aromatic region (9-7ppm)
shows the splitting of the pyridine rings associated with the metal complex. The fact that the splitting is not duplicated suggests
that this metal complex has a plane of symmetry, which is confirmed by analysis if the crystal structure.
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The electronic absorption spectrum of ReO(dpk-OEt)Cl2 showed absorbances at 342,
315, and 249 nm, which indicates both the cleavage of the Re-Re quadruple bond as the δ-δ*
transition at 685 nm is absent, and the coordination of the dpk-OEt ligand to the rhenium metal
center. The IR spectrum exhibits absorptions consistent with the coordination of the dpk-OEt
ligand to the rhenium center. In addition, the strong absorbance at 965 cm-1 corresponds to the
Re=O stretch, also reported at 965 cm-1 by Gonzàlez et al.32 The 1H NMR spectrum (Fig. 22)

Re-O: 1.98 Å
Re=O: 1.69 Å
O-Re=O: 156.7°

Figure 23: X-ray crystal structure showing ReO(dpk-OEt)Cl2. Rhenium, Oxygen, Chlorine,
Nitrogen, Carbon, Hydrogen (White). (Gonzàlez, et al. 2011).
shows three major resonances in the aromatic region between 7.5 and 8.5 ppm, which would be
consistent with the expectation of ReO(dpk-OEt)Cl2 being a symmetric species. The quartet at
8.0 ppm is suggestive of proton coupling occurring within the pyridine rings, which would be
confirmed by future 2-D NMR experiments such as COSY and HMQC. The upfield resonances
at 3.65 ppm and 1.30 ppm correspond to the CH2 and CH3 protons on the ethoxyl group,
respectively. The diamagnetic nature of this low spin d2 center suggests the two d-electrons
occupy the same molecular orbital, highlighting the labile nature of the ReO(dpk-OEt)Cl2
complex. The x-ray structure,
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shown in Figure 23, shows ReO(dpk-OEt)Cl2 to be a distorted octahedron, as the bond angle
between the oxo, rhenium center, and singly-bonded oxygen is 156.7°.32 The Re-oxo bond length
is 1.69 Å, indicative of a strong π interaction. The Re-O bond length of 1.98 Å is consistent with
a Re-O singly-bonded oxygen.
This complex is both similar and different to Re(Py2NO)Cl3 as a metallointercalator
intermediate. Like Re(Py2NO)Cl3, the supporting group of ReO(dpk-OEt)Cl2 is tridentate,
binding to three of the six open binding sites on the rhenium metal. This shared nature of the
binding of the supporting group makes ReO(dpk-OEt)Cl2 a viable candidate for a
metallointercalator.
Conversely, ReO(dpk-OEt)Cl2 is different in that it is an oxo complex: a metal complex
in which a single oxygen atom forms a double-bond with a metal. This complex differs from the
originally proposed [Re(Py2NO)(H2O)dppz]3+ in that the H2O molecule can be more easily
substituted with other substituent groups than the oxygen atom. This will likely affect the range
of DNA binding behaviors that [ReO(dpk-OEt)dppz]2+ will possess, since the oxygen atom has a
high binding affinity to the rhenium metal, and thus will be more difficult to substitute with other
groups in order to alter the DNA binding behavior of the complex. This does not, however,
render [ReO(dpk-OEt)dppz]2+ useless as a metallointercalator. The doubly-bonded oxygen atom
will be able to exhibit hydrogen bonding with base pairs in the major and minor grooves of
DNA. There have also been no reports of a metallointercalator complex containing an oxo,
which would render [ReO(dpk-OEt)dppz]2+ the first representative of a novel class of
metallointercalators.
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Synthesis of [ReO(dpk-OEt)dppz]2+
ReO(dpk-OEt)Cl2 was then refluxed with Ag+ and dppz in acetonitrile in an attempt to
synthesize the metallointercalator [ReO(dpk-OEt)dppz]2+ (Fig. 24). After the AgCl precipitate
was filtered off, addition of saturated aqueous KPF6 solution to the reaction filtrate yielded a
red/brown solid. An IR spectrum of the crude product shows similarities between the vibrations
of the ReO(dpk-OEt)Cl2 intermediate and the product believed to be [ReO(dpk-OEt)dppz][PF6]2.
Major vibrations shifted by 50 cm-1 or less between the two spectra, suggesting that the dpk-OEt

Figure 24: Chemical reaction of ReO(dpk-OEt)Cl2, silver trifluoromethanesulfonate, and
dppz in acetonitrile to produce the metallointercalator [ReO(dpk-OEt)dppz]2+.

ligand remained intact and that dppz is coordinated to the two open binding sites previously
occupied by the halide atoms. In addition, a vibration at 829 cm-1 is present, which corresponds
to the PF6- counterion. This value is shifted roughly 20 cm-1 from the P-F stretch corresponding
to a sample of KPF6, strongly suggesting that PF6- is present in the sample as an anion.
Electronic absorption data shows peaks which are similar in structure between the ReO(dpkOEt)Cl2 and [ReO(dpk-OEt)dppz]2+ samples (342, 315, and 249 nm and 374, 358, and 277 nm,
respectively). These absorptions are shifted 30-40 nm between the samples, which is a promising
suggestion that dppz is coordinated to the rhenium metal center.
A 1H NMR spectrum of the sample shows five resonances in the aromatic region (Fig.
26). Three of these aromatic resonances appear to be triplets and quartets, suggesting hydrogen
coupling on the dpk-OEt ligand and dppz. This will be determined through future 2-D NMR
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experiments, specifically COSY and HMQC. The ReO(dpk-OEt)Cl2 resonances in the aromatic
region appear to be shifted, which suggests the coordination of dppz to the rhenium metal center,
and thus the synthesis of the metallointercalator complex [ReO(dpk-OEt)dppz]2+. The upfield
region consists of a triplet at 0.95 ppm, corresponding to the CH3 protons on the ethoxyl group of
dpk-OEt, and a small resonance at 3.05 ppm which is likely a quartet associated with the CH 2
protons of the ethoxyl group. These signals are less pronounced than the ethoxyl group signals in
Figure 23, which suggests that this group may have the ability to reversibly add to and leave the
carbonyl carbon, forming free ethanol.
The reversible nature of the interaction of di-2-pyridyl ketone and ethanol can be seen in
the isolation of a di-rhenium byproduct from the reaction of ReO(dpk-OEt)Cl2 with silver and
dppz. A preliminary crystal structure of this byproduct (Fig. 25) reveals an edge-sharing
bioctahedral structure where two ReIII centers are bridged by a chloride and an oxo group. One of
the rhenium centers is coordinated by a tridentate dpk-OEt group, while the second rhenium
center is supported by a bidentate di-2-pyridyl ketone ligand. The two rhenium centers are
separated by 2.494 Å

Figure 25: X-ray crystal structure of a di-rhenium byproduct. The byproduct is a ReIII-ReIII
dimer with a bridging oxygen and a bridging chloride, shown in red and green, respectively.
Dpk is shown as a ligand on one of the rhenium centers, while dpk-OEt is shown as a ligand
on the other rhenium center. Rhenium, Oxygen, Chlorine, Nitrogen, Carbon, Hydrogen
(White).
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Figure 26: NMR spectrum of the metal complex believed to be [ReO(dpk-OEt)dppz][PF6]2 (with integration)in deuterated
acetonitrile. The splitting shown in the enlarged aromatic region (9-6.5ppm) has shifted slightly from Figure 2, suggesting a
change in coordination. Another signal in the aromatic region at 9.7 ppm is enlarged. The increased number of peaks also
suggest the presence of another aromatic compound coordinated with the metal center, most likely dppz.
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Conclusions
We are continuing to work toward obtaining Re(Py2NO)Cl3 as a crystalline product, after
having discovered a synthesis method which yields a solid product. We have also synthesized the
metallointercalator intermediate ReO(dpk-OEt)Cl2 through a novel synthesis method which
produced higher yields than the literature had reported. This complex was then reacted with Ag+
and dppz in an attempt to produce the metallointercalator [ReO(dpk-OEt)dppz]2+. A solid
product precipitated as a PF6- salt, which is believed to be the desired metallointercalator. All
products have been characterized by IR, NMR, and UV/Vis spectroscopy, and x-ray diffraction
studies have been conducted on single crystal samples. Attempts to obtain the metallointercalator
[ReO(dpk-OEt)dppz]2+ are ongoing.
Future work will consist of obtaining crystals of both Re(Py2NO)Cl3 and [ReO(dpkOEt)dppz]2+ for X-ray diffraction studies. Further syntheses will also attempt to increase the
yield of Re(Py2NO)Cl3. Upon X-ray diffraction studies of Re(Py2NO)Cl3, further syntheses will
attempt to produce the metallointercalator [Re(Py2NO)(H2O)dppz]3+ using dppz and Ag+ salts.
Upon X-ray diffraction studies of [ReO(dpk-OEt)dppz]2+, DNA binding studies will be
commenced in collaboration with Dr. Thayaparan Paramanathan of the Department of Physics at
Bridgewater State University in order to achieve the ultimate goal of this project: to understand
how these metallointercalators interact with DNA, and to determine their viability as DNA
damage probes.
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